![]() |
市場調查報告書
商品編碼
1725167
2032 年腦健康補充品市場預測:按產品類型、補充劑形式、年齡層、通路、應用和地區進行的全球分析Brain Health Supplements Market Forecasts to 2032 - Global Analysis By Product Type, Supplement Form, Age Group, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,全球大腦健康補充劑市場預計在 2025 年達到 132 億美元,到 2032 年將達到 289 億美元,預測期內的複合年成長率為 11.8%。
大腦健康補充劑是一種旨在增強認知功能、記憶力、注意力和整體大腦功能等營養配方。它們通常由天然成分組成,如Omega-3脂肪酸、B 群維生素、銀杏和精神活性藥物,旨在提高頭腦清晰度並防止與老齡化相關的認知能力下降。人們經常使用這些補充劑來提高認知警覺性,緩解壓力,並透過均衡的生活方式和飲食來維持神經系統健康。
根據美國退休人員協會 (AARP) 2019 年大腦健康和膳食補充劑調查,超過四分之一 (26%) 的 50 歲及以上美國成年人服用至少一種大腦健康補充劑。
提高心理健康意識
人們對注意力不集中、缺乏專注力、記憶力差、焦慮和憂鬱症等心理健康問題的認知不斷提高,正在推動市場成長。消費者對自己的認知健康變得更加積極主動,更喜歡預防性的選擇而不是被動的治療。隨著有關心理健康的討論變得越來越主流且不再受到歧視,越來越多的人開始尋找物質來支持他們的大腦。此外,老化社會的日益加劇引發了人們對認知能力下降和神經系統疾病的擔憂,從而擴大了消費者群體。該行業也受益於擴大使用天然和草本保健食品作為認知支持藥物的替代品。
缺乏法律規範
由於缺乏對心理健康補充劑生產的嚴格監管,生產商可以在沒有足夠監管核准的情況下推出產品,從而產生誤導性和虛假宣傳,損害消費者的信任。如果長期服用或與其他藥物混合服用,此類補充劑可能會產生負面副作用。此外,許多大腦健康補充劑缺乏強力的科學數據來支持其有效性,臨床證據非常有限。
針對特定認知需求的產品
製造商正在投資研發,利用專有化學成分創造針對特定認知功能的創新配方。對解決增強記憶力、提高注意力、減輕壓力和改善睡眠品質等特定問題的產品的需求不斷成長,推動著市場的成長。此外,隨著運動產業對增強運動員大腦功能的興趣日益濃厚,新的機會也隨之出現。年輕一代對心理健康的興趣日益濃厚,以及旨在提高職業表現的補充劑市場的蓬勃發展,為該行業的公司創造了極具吸引力的機會。
仿冒品
許多市售補充劑含有營養成分標籤上未列出的成分,或者其含量與聲稱的含量不同,從而使用戶面臨過量攝取的潛在不良影響。根據 Nuvance Health 的報告,一些聲稱有助於認知功能的非處方產品可能含有禁用藥物。此外,該行業缺乏標準化的測試和品管技術,使得消費者難以區分合法產品和詐騙產品。誤導性的行銷宣傳和薄弱的監管執法進一步加劇了這個問題,阻礙因素了市場成長。
新冠疫情推動了大腦健康補充劑的業務,並鼓勵人們在社群媒體網站上自由地揭露自己患有精神疾病、壓力、焦慮和情緒低落的經歷。透明度的提高導致對大腦健康補充劑的需求增加。此外,疫情導致人們更加關注改善身體健康和整體生活品質,為製造商與心理健康影響者合作銷售產品提供了機會。
維生素和礦物質市場預計將成為預測期內最大的市場
預計在預測期內,維生素和礦物質部分將佔據最大的市場佔有率。該指南基於大量科學證據,表明關鍵維生素和礦物質在認知功能中發揮作用,並可能有助於預防與老齡化相關的認知能力下降和阿茲海默症和失智症發育障礙。這些補充劑可透過各種分銷管道廣泛取得,包括藥局、超級市場和網店。此外,由於消費者熟悉維生素和礦物質補充劑,並且與其他類別相比價格相對便宜,因此市場滲透率很高。醫療保健專業人士的建議以及人們對微量營養素缺乏對認知健康影響的認知不斷提高也有助於推動該領域的擴展。
預計在預測期內,壓力和焦慮部分將以最高的複合年成長率成長。
預計壓力和焦慮部分將在預測期內見證最高的成長率。這一顯著成長是由於人們對心理健康問題的認知不斷提高,以及人們越來越接受自然治療方法作為標準藥物治療的替代品。緊張的都市區生活方式和職場壓力正在刺激對壓力管理產品的需求。此外,適應原始草藥和胺基酸等成分組合的進步正在創造出更有效的緩解壓力的配方。這些補充劑被納入整體健康養生法,並得到醫療保健專業人士越來越多的推薦,這也推動了該類別的成長。
在預測期內,由於腦部疾病盛行率上升、醫療保健基礎設施完善以及消費者對認知健康的認知提高,預計北美將佔據最大的市場佔有率。美國佔據北美市場的三分之二以上,隨著人們對心理健康和認知改善的認知不斷提高,推動了消費者在膳食補充劑上的支出增加。此外,該地區擁有大型企業、尖端研究中心和良好的法規環境。龐大的經銷網路以及透過零售連鎖店和電子商務平台輕鬆獲得的產品進一步增強了北美市場的優勢。
預計亞太地區在預測期內的複合年成長率最高。這一顯著成長是由於消費者對補充劑益處的認知不斷提高、對天然補充劑而非藥物的偏好以及阿茲海默症的不斷上升所推動的。在中國、印度和日本,傳統醫藥在這些國家的文化中根深蒂固,市場滲透率很高。此外,世界衛生組織(WHO)估計,全球近80%的人口依賴傳統醫藥來滿足基本健康需求,尤其是在中國和印度等開發中國家。醫療保健支出的增加、慢性病盛行率的上升以及草藥的供應都促進了該地區的崛起。
According to Stratistics MRC, the Global Brain Health Supplements Market is accounted for $13.2 billion in 2025 and is expected to reach $28.9 billion by 2032 growing at a CAGR of 11.8% during the forecast period. Brain health supplements are nutritional formulations designed to enhance cognitive function, memory, focus, and total cerebral performance. They generally comprise natural components such as omega-3 fatty acids, B vitamins, ginkgo biloba, and nootropics designed to improve mental clarity and safeguard against age-related cognitive deterioration. People frequently use these supplements to enhance cognitive alertness, alleviate stress, or maintain neurological well-being in a balanced lifestyle and diet.
According to the AARP 2019 Brain Health and Dietary Supplements Survey, more than a quarter (26%) of U.S. adults aged 50 and older take at least one supplement for brain health reasons.
Rising mental health awareness
The growing awareness of mental health issues such as loss of attention, focus, failing memory, anxiety, and depression is propelling the market growth. Consumers are becoming more proactive about their cognitive health, preferring preventive options over reactive therapies. The mainstream of mental health conversations has lessened stigma, prompting more people to seek brain-supporting substances. Furthermore, the expanding aging population is concerned about cognitive decline and neurological illnesses, broadening the consumer base. The industry is also benefiting from the growing use of natural and herbal health products as alternatives to pharmaceutical therapies for cognitive support.
Lack of regulatory oversight
The lack of strong rules on mental health supplement production permits producers to release products without adequate regulatory approval, resulting in misleading or false claims that damage consumer trust. These supplements may have negative side effects if taken for an extended period of time or when mixed with other medications. Furthermore, many brain health supplements lack strong scientific data to support their efficacy, with very limited clinical evidence to back it up.
Targeted products for specific cognitive needs
Manufacturers are investing in R&D to generate creative formulations with unique chemicals that target specific cognitive functions. The rising demand for goods that address specific problems such as memory enhancement, attention improvement, stress reduction, and sleep quality is propelling market growth. Furthermore, the sports industry's growing interest in strengthening players' brain efficacy is creating new opportunities. The growing attention on mental well-being among younger generations, as well as the burgeoning market for supplements aimed at professional performance enhancement, is creating attractive opportunities for industry players.
Counterfeit products
Many marketed supplements may contain components that are not stated on nutrition labels or in quantities that differ from what is claimed, exposing users to potential negative effects from excessive usage. Nuvance Health reports that some over-the-counter products claiming to help cognitive function may contain prohibited pharmaceuticals. Furthermore, the lack of standardized testing and quality control techniques throughout the sector makes it difficult for consumers to discern between legal and fraudulent items. Deceptive marketing claims and insufficient regulatory enforcement compound this problem, creating impediments to market growth.
The COVID-19 epidemic boosted the business of brain health supplements, encouraging people to freely disclose their experiences with mental illness, stress, anxiety, and mood swings on social media sites. This enhanced transparency resulted in a rise in demand for brain health supplements. Furthermore, the pandemic increased the emphasis on improving physical health and overall quality of life, opening up chances for manufacturers to sell their products in collaboration with mental health influencers.
The vitamins and minerals segment is expected to be the largest during the forecast period
The vitamins and minerals segment is expected to account for the largest market share during the forecast period. This guidance is based on considerable scientific evidence that vital vitamins and minerals play a role in cognitive function and are useful in preventing age-related cognitive decline and developmental illnesses such as Alzheimer's and dementia. These supplements are widely available through various distribution channels, including pharmacies, supermarkets, and internet shops. Furthermore, high market penetration has resulted from consumer familiarity with vitamin and mineral supplements and their relatively inexpensive cost compared to other categories. Healthcare professional recommendations and increased awareness of the impact of micronutrient deficiencies on cognitive health are also helping to drive the segment's rise.
The stress and anxiety segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the stress and anxiety segment is predicted to witness the highest growth rate. This significant growth is being driven by rising awareness of mental health issues and a growing acceptance of natural alternatives to standard pharmacological treatments. High-stress urban lifestyles and workplace pressures are fueling demand for stress-management products. Furthermore, advances in ingredient combinations, such as adaptogenic herbs and amino acids, have resulted in the creation of more effective stress-relief formulas. The integration of these supplements into holistic wellness regimens, as well as increased recommendations by healthcare professionals, is accelerating the segment's rise.
During the forecast period, the North America region is expected to hold the largest market share due to the rising prevalence of brain illnesses, well-established healthcare infrastructure, and high consumer awareness of cognitive health. The United States accounts for more than two-thirds of the North American market, with rising consumer expenditure on health supplements spurred by increased awareness of mental health and cognitive well-being. Furthermore, the region benefits from the presence of large businesses, cutting-edge research centers, and a strong regulatory environment. The enormous distribution networks and product accessibility via retail chains and e-commerce platforms further enhance North America's market supremacy.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This remarkable growth is being driven by greater consumer awareness of the benefits of these supplements, a preference for natural supplements over medicines, and an increasing prevalence of Alzheimer's disease. The market has demonstrated substantial penetration in China, India, and Japan, where traditional medicine has deep cultural roots. Furthermore, the World Health Organization estimates that nearly 80% of the world's population relies on traditional medicine for basic health requirements, particularly in developing nations such as China and India. Increased healthcare expenditure, rising chronic disease incidence, and the availability of herbal plants all contribute to the region's rise.
Key players in the market
Some of the key players in Brain Health Supplements Market include Natural Factors Nutritional Products Ltd, Onnit Labs, Inc., Purelife Bioscience Co., Ltd, Intelligent Labs, Accelerated Intelligence Inc., NOW Foods, HVMN Inc., Teva Pharmaceutical Industries Ltd., Peak Nootropics, AlternaScript LLC, Quincy Bioscience, Liquid Health, Inc., Reckitt Benckiser Group PLC, DSM (Koninklijke DSM NV), BASF SE, Lonza Group, Glanbia PLC and Archer-Daniels-Midland Company (ADM).
In September 2024, Teva presented new Phase 3 data for TEV-749, a once-monthly subcutaneous long-acting injectable for adult patients diagnosed with schizophrenia. The company stated, "Teva is dedicated to building on its commitment to neuroscience by developing new long-acting injectable treatment options like TEV-749".
In May 2024, Teva announced the U.S. FDA approval of AUSTEDO XR, a once-daily tablet for treating chorea associated with Huntington's disease and tardive dyskinesia.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.